• English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
The UK Prime Ministers Office: Prime Minister Burnham held talks with business groups and said the UK will act "more aggressively" if markets and regulations fail to meet expectations.July 24th - U.S. new home sales rebounded for the first time in three months in June, driven by significant price cuts from developers that offset high mortgage rates and weak consumer confidence. Junes annualized new home sales rose 1.6% year-over-year to an average of 628,000 units, exceeding the expected 607,000 units. The median selling price fell 2.7% year-over-year to $398,300, marking the fifth year-over-year decline in six months this year. The improved sales in June likely reflect substantial discounts, as developers continue to offer promotions and price reductions to stimulate weak market demand.On July 24th, Shanghai Auntie (02589.HK) issued a positive profit forecast, expecting to record a profit of approximately RMB304 million to RMB325 million for the first half of the year, representing an increase of approximately 50% to 60% compared to a profit of RMB203 million in the same period last year. The Group expects to record an adjusted profit (non-IFRS accounting standards) of approximately RMB331 million to RMB356 million for the reporting period, representing an increase of approximately 36% to 46% compared to an adjusted profit of RMB244 million in the same period last year.Schlumberger (SLB.N): The commodity environment is expected to remain range-bound, which is favorable for upstream investment.Schlumberger (SLB.N): Free cash flow is expected to be higher in the second half of 2026 than in the first half.

CVS And Walgreens Will Sell Abortion Drugs

Skylar Williams

Jan 05, 2023 11:30

7.png


Walgreens Boot Alliance Inc and CVS Health Corp (NYSE:CVS) plan to seek certification to dispense abortion pills after the FDA allowed retail pharmacies to offer the medicine for the first time in the U.S.


Walgreens said in an email, "We're registering, training our pharmacists, and reviewing our pharmacy network to determine where we distribute products with additional FDA requirements. We'll dispense these in accordance with federal and state laws."


CVS Health plans to seek certification to dispense mifepristone in legal states.


The FDA finalized a rule allowing pharmacists to sell mifepristone on Tuesday.


The health agency finalized the changes after analyzing Danco Laboratories and GenBioPro's additional applications.


The regulation change will make medication abortion, which accounts for more than half of U.S. abortions, more available in states where abortion is allowed.


In view of the abortion issue, retail pharmacists must decide whether to sell the pill and where.